Agility Capital, LLC

Website Links

Description

Agility Capital was founded in 2000 with a clear focus: provide innovative short-term loans to private venture-backed and Small Cap public companies. Our lending strategy is simple: be the most creative and responsive lender for technology companies. We provide services tailored to the immediate needs of our clients. We act fast and precise to provide our clients the service expected in today's competitive marketplace.

In his 20 years of research, development, marketing, and management experience in the biosciences industry, David's corporate positions have included Director of Technology & Business Development, Global Product Manager, and Vice President of R&D. His career has spanned both diagnostics and therapeutics, and he was instrumental in the construction of several ground-breaking alliances between diagnostic and biopharmaceutical companies for the development of new predictive assays for targeted oncology therapies.

Our loans include but are not limited to: mezzanine financing, primary bridge loans, lines of credit, factoring lines of credit, non-formula lines of credit, and restructuring debt. We specialize in the type of loans that are necessary to provide an entrepreneur with time and operating capital to successfully achieve the next financing milestone, whether it is a private equity investment, the sale of the company, or public offering.

Agility's Management Team brings a variety of skills and experience to the process of providing innovative debt financing products to emerging growth companies. The team's collective experience includes over 500 debt transactions including; short term working capital lines of credit, bridge financing, amortizing term loans and acquisition financing. The underlying philosophy is to provide customized debt solutions, without cumbersome financial covenants.

Fact sheet

Companies nearby